Richardson, P. G., Schjesvold, F., Weisel, K., Moreau, P., Anderson, L. D., White, D., Rodriguez-Otero, P., Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., Dürig, J., Pavic, M., Salomo, M., Beksac, M., Oriol, A., Lindsay, J., Liberati, A. M., Galli, M., ... Dimopoulos, M. (2022). Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics. European Journal of Haematology, 108(1), 73-83. https://doi.org/10.1111/ejh.13706
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics. / Richardson, Paul G.; Schjesvold, Fredrik; Weisel, Katja et al.
In:
European Journal of Haematology, Vol. 108, No. 1, 01.2022, p. 73-83.
Research output: Contribution to journal › Article › peer-review
Richardson, PG, Schjesvold, F, Weisel, K, Moreau, P, Anderson, LD, White, D, Rodriguez-Otero, P, Sonneveld, P, Engelhardt, M, Jenner, M, Corso, A, Dürig, J, Pavic, M, Salomo, M, Beksac, M, Oriol, A, Lindsay, J, Liberati, AM, Galli, M, Robak, P, Larocca, A, Yagci, M, Vural, F, Kanate, AS, Jiang, R, Grote, L, Peluso, T & Dimopoulos, M 2022, 'Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics', European Journal of Haematology, vol. 108, no. 1, pp. 73-83. https://doi.org/10.1111/ejh.13706
Richardson PG, Schjesvold F, Weisel K, Moreau P, Anderson LD, White D et al. Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics. European Journal of Haematology. 2022 Jan;108(1):73-83. doi: 10.1111/ejh.13706
Richardson, Paul G. ; Schjesvold, Fredrik ; Weisel, Katja et al. / Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma : A subanalysis of OPTIMISMM by clinical characteristics. In: European Journal of Haematology. 2022 ; Vol. 108, No. 1. pp. 73-83.
@article{51aab74fa61342cda8b23411aee9866d,
title = "Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics",
keywords = "aged, chromosome aberrations, multiple myeloma, pomalidomide, renal insufficiency",
author = "Richardson, {Paul G.} and Fredrik Schjesvold and Katja Weisel and Philippe Moreau and Anderson, {Larry D.} and Darrell White and Paula Rodriguez-Otero and Pieter Sonneveld and Monika Engelhardt and Matthew Jenner and Alessandro Corso and Jan D{\"u}rig and Michel Pavic and Morten Salomo and Meral Beksac and Albert Oriol and Jindriska Lindsay and Liberati, {Anna Marina} and Monica Galli and Pawel Robak and Alessandra Larocca and Munci Yagci and Filiz Vural and Kanate, {Abraham S.} and Ruiyun Jiang and Lara Grote and Teresa Peluso and Meletios Dimopoulos",
note = "Publisher Copyright: {\textcopyright} 2021 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.",
year = "2022",
month = jan,
doi = "10.1111/ejh.13706",
language = "English",
volume = "108",
pages = "73--83",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "1",
}
TY - JOUR
T1 - Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma
T2 - A subanalysis of OPTIMISMM by clinical characteristics
AU - Richardson, Paul G.
AU - Schjesvold, Fredrik
AU - Weisel, Katja
AU - Moreau, Philippe
AU - Anderson, Larry D.
AU - White, Darrell
AU - Rodriguez-Otero, Paula
AU - Sonneveld, Pieter
AU - Engelhardt, Monika
AU - Jenner, Matthew
AU - Corso, Alessandro
AU - Dürig, Jan
AU - Pavic, Michel
AU - Salomo, Morten
AU - Beksac, Meral
AU - Oriol, Albert
AU - Lindsay, Jindriska
AU - Liberati, Anna Marina
AU - Galli, Monica
AU - Robak, Pawel
AU - Larocca, Alessandra
AU - Yagci, Munci
AU - Vural, Filiz
AU - Kanate, Abraham S.
AU - Jiang, Ruiyun
AU - Grote, Lara
AU - Peluso, Teresa
AU - Dimopoulos, Meletios
N1 - Publisher Copyright:
© 2021 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.
PY - 2022/1
Y1 - 2022/1
KW - aged
KW - chromosome aberrations
KW - multiple myeloma
KW - pomalidomide
KW - renal insufficiency
UR - http://www.scopus.com/inward/record.url?scp=85115264782&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115264782&partnerID=8YFLogxK
U2 - 10.1111/ejh.13706
DO - 10.1111/ejh.13706
M3 - Article
C2 - 34496096
AN - SCOPUS:85115264782
SN - 0902-4441
VL - 108
SP - 73
EP - 83
JO - European Journal of Haematology
JF - European Journal of Haematology
IS - 1
ER -